Keiichi Fujiwara

The platelet-sparing effect of paclitaxel is not related to changes in the pharmacokinetics of carboplatin

Yasumasa Tanaka, Ichiro Kohno, K. Fujiwara, 2001, Cancer Chemotherapy and Pharmacology.

Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai

Yasunari Miyagi, Ichiro Kohno, Eriko Aotani, 2005, Gynecologic oncology.

Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.

Keitaro Matsuo, Masahiro Tabata, K. Matsuo, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.

Ignace Vergote, Beth Y Karlan, Christian Marth, 2016, Gynecologic oncology.

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.

Val Gebski, Philipp Harter, Tomasz Huzarski, 2017, The Lancet. Oncology.

FIGO Committee for the Ethical Aspects of Human Reproduction and Women’s Health

Régine P.M. Steegers-Theunissen, E. A. Stewart, Toshihiro Yanagihara, 1999, Gynecologic and Obstetric Investigation.